Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
Kathleen E. Bethin, MD, PhD, and Lucy D. Mastrandrea, MD, PhD, were local investigators in a successful worldwide clinical trial that confirmed that a fast-acting insulin is safe for children with diabetes mellitus.
As WNY's most extensive practice, with 500+ physicians in 18 different practices, and representation in virtually every medical specialty, UBMD provides care to you, next-level training to the future generation of doctors and researching to answer today's top medical mysteries.
The University at Buffalo has been awarded a five-year, $21.7 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) to continue Buffalo’s rapid trajectory growing its health care and research sectors.
The Madras Diabetes Research Foundation (MDRF) has named Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, as the recipient of its 2020 Lifetime Contribution Award.
Researchers have discovered through a vast and novel computational library the first molecules that can modulate circadian rhythms by binding with high selectivity to the MT1 melatonin receptor in the biological clock.
Symptoms of cervical myelopathy may appear in different ways. Some may feel pain in the neck, others have pain or numbness elsewhere in the body at/below the compressed area of the spinal cord, or some may experience both.
Recent FDA approval of a fast-acting insulin for children with diabetes mellitus came about with the help of UB, UBMD Pediatrics and Oishei Children’s Hospital, and some highly committed Western New York families.